A patient taking Naproxen for arthritis should show which outcome to indicate effective treatment?

Naproxen is a non-steroidal anti-inflammatory drug (NSAID) commonly used to relieve pain, reduce inflammation, and lower fever. It is particularly effective for conditions like arthritis, where reduced joint pain and inflammation are crucial for improving the patient’s quality of life and mobility.

The outcome indicating effective treatment with Naproxen in a patient with arthritis is joint pain relief. This outcome signifies that the medication is working to alleviate the discomfort and inflammation associated with arthritis, allowing the patient to engage more fully in their daily activities and improving their overall well-being. Effective management of pain is a primary goal in treating arthritic conditions, and achieving this effect would demonstrate that the therapeutic intervention is successful.

In contrast, resolution of infection, tumor spread prevention, and increased bone mass do not relate to the primary therapeutic goals of Naproxen. Naproxen does not treat infections, prevent tumor growth, or directly impact bone density, making joint pain relief the most relevant and correct outcome for patients on this medication for arthritis.